SMART Thinking: a Review of Recent Developments in Sequential Multiple Assignment Randomized Trials
- 385 Downloads
With the increasing interest in personalized medicine, over the last decade, sequential multiple assignment randomized trials (SMARTs) have become a more common fixture of the clinical trial landscape. Primarily of use in the identification of dynamic treatment regimes, they have experienced a shift from the more complex designs of the past to the considerably streamlined versions seen today. In this review, we summarize their history, outline recent and ongoing examples, and discuss some of the important methodological developments for their design and implementation.
KeywordsSMARTs Dynamic treatment regimes Adaptive treatment strategies Longitudinal data Causal inference
This work is funded by Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grants. Dr. Moodie is sponsored by a Chercheur-Boursier career award from the Fonds de Recherche du Québec-Santé (FRSQ), and Dr. Wallace is partially supported by a training scholarship from the Canadian Network for Advanced Interdisciplinary Methods for comparative effectiveness research, Drug Safety and Effectiveness Network (CAN-AIM DSEN).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 5.Almirall D, Lizotte D, Murphy S. SMART design issues and the consideration of opposing outcomes, a discussion of evaluation of viable dynamic treatment regimes in a sequentially randomized trial of advanced prostate cancer by Wang, Rotnitzky, Lin, Millikan, and Thall. Journal of the American Statistical Association. 2012;107(498):509–12.CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick ID, Canive JM, et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophrenia Bulletin. 2003;29:15–31.CrossRefPubMedGoogle Scholar
- 8.Pineau J, Bellemare MG, Rush JA, Ghizaru A, Murphy SA. Constructing evidence- based treatment strategies using methods from computer science. Drug and Alcohol Dependence. 2007;88(Supplement 2(0)):S52–60. Customizing treatment to the patient: adaptive treatment strategies. Available from: http://www.sciencedirect.com/science/article/pii/S0376871607000270.
- 10.Shortreed SM, Moodie EEM. Estimating the optimal dynamic antipsychotic treatment regime: evidence from the sequential multiple-assignment randomized Clinical Antipsychotic Trials of Intervention and Effectiveness schizophrenia study. Journal of the Royal Statistical Society, Series C. 2012;61(4):577–59.CrossRefGoogle Scholar
- 11.Zhao Y, Zeng D. Recent development on statistical methods for personalized medicine discovery. Frontiers of Medicine. 2013;7(1):102–10. Available from: doi: 10.1007/s11684-013-0245-7.
- 13.Moodie EEM, Karran J, Shortreed SM. A case study of the generalizability and retention rate of a SMART study. 2015; Submitted.Google Scholar
- 15.Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. The New England Journal of Medicine. 1999;341:1165–73.CrossRefPubMedGoogle Scholar
- 17.Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman PP, et al. Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine. Blood. 2001;98:548–53.CrossRefPubMedGoogle Scholar
- 18.Tummarello D, Mari D, Graziano F, Isidori P, Cetto G, Pasini F, et al. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses. Cancer. 1997;80:2222–9.CrossRefPubMedGoogle Scholar
- 19.Auyeung SF, Long Q, Royster EB, Murthy S, McNutt MD, Lawson D, et al. Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy. Clinical Trials. 2009;6:480–90.CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Naar-King S, Ellis DA, Idalski AC, Templin T, Jacques-Tiura AJ, Brogan KH, et al. Journal of Clinical Child and Adolescent Psychology. 2015.Google Scholar
- 23.Nahum-Shani I, Qian M, Almirall D, Pelham WE, Gnagy B, Fabiano GA, et al. Q-learning: a data analysis method for constructing adaptive interventions. Psychological methods. 2012;17(4):478–94. Available from: http://search.proquest.com.proxylib.umich.edu/docview/1314310841?accountid=14667.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Mateos MV, Orio A, Martínez-López J, Gutiérrez N, Teruel AI, de Paz R, et al. Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial. The Lancet Oncology. 2010;11:934–41.CrossRefPubMedGoogle Scholar
- 27.Jones H. H. Jones. Reinforcement-based treatment for pregnant drug abusers (HOME II). National Institutes of Health, Bethesda, MD. 2010; Available from: http://clinicaltrials.gov/ct2/show/NCT01177982
- 30.Gunlicks-Stoessel M, Mufson L, Westervelt A, Almirall D, Murphy S. A pilot SMART for developing an adaptive treatment strategy for adolescent depression. Journal of Clinical Child and Adolescent Psychology. 2015;18:1–15.Google Scholar
- 31.Chronis-Tuscano A, Wang CH, Strickland J, Almirall D, Stein M. Personalized treatment of mothers with ADHD and their young at-risk children: a SMART pilot. Journal of Clinical Child and Adolescent Psychology. 2016.Google Scholar
- 34.•Kosorok MR, Moodie EEM. Adaptive treatment strategies in practice. 2016. This book provides an overview of the personalized medicine literature, from planning trials to data analysis. It is written with a wide variety of readers in mind, ranging from the discussion of broad principles to specialist implementations.Google Scholar
- 35.Kilbourne AM, Almirall D, Eisenberg D, Waxmonsky J, Goodrich DE, Fortney JC, et al. Protocol: Adaptive Implementation of Effective Programs Trial (ADEPT): cluster randomized SMART trial comparing a standard versus enhanced implementation strategy to improve outcomes of a mood disorders program. Implementation Science. 2014;9.Google Scholar
- 39.Watkins CJCH. Learning from delayed rewards, PhD dissertation. Cambridge, England: Cambridge University Press; 1989.Google Scholar
- 40.Sutton RS, Andrew GB. Reinforcement learning: an introduction. Cambridge: MIT press; 1998.Google Scholar